Pari CR 25 is a generic controlled-release form of paroxetine, a selective serotonin reuptake inhibitor (SSRI) widely prescribed for various psychiatric conditions. This formulation offers sustained serotonin elevation in the brain, which aids in stabilizing mood and relieving anxiety and depressive symptoms. The controlled-release design enhances patient compliance by providing a smoother medication effect and reducing side effects associated with peak doses.

- Sleep & Mental Health > Depression, Anxiety, PTSD Pari CR 25 is effective for major depressive disorder (MDD), generalized anxiety disorder (GAD), panic disorder, and post-traumatic stress disorder (PTSD). It helps to restore emotional balance and manage stress responses comprehensively. > Obsessive-Compulsive Disorder (OCD) Approved by the FDA for OCD, it reduces compulsive behaviors and intrusive thoughts through serotonin modulation, improving quality of life for affected individuals. > Panic Disorder It is a key treatment for panic disorder, reducing panic attack frequency and severity and preventing long-term recurrence.

Paroxetine blocks serotonin reuptake transporters in the CNS, increasing synaptic serotonin levels. This action corrects neurotransmitter imbalances implicated in mood and anxiety disorders, leading to symptom relief and improved mental health.

Adult Dosing - Depression & Major Depressive Disorder (MDD): IR: Start 20 mg daily; Maintenance 20–50 mg; Max 50 mg CR: Start 25 mg daily; Maintenance 25–62.5 mg; Max 62.5 mg Dose escalation by 10 mg (IR) or 12.5 mg (CR) weekly. Treatment duration usually several months, with documented efficacy up to one year. - Social Anxiety Disorder (SAD): IR: Start 20 mg daily; Maintenance 20–60 mg; Max 60 mg CR: Start 12.5 mg daily; Maintenance 12.5–37.5 mg; Max 37.5 mg Treatment period up to 12 weeks, with weekly dose increments. - Panic Disorder (PD): IR: Start 10 mg daily; Maintenance 10–40 mg; Max 60 mg CR: Start 12.5 mg daily; Maintenance 12.5–75 mg; Max 75 mg Typically treated up to 12 weeks with weekly dose increases. - Premenstrual Dysphoric Disorder (PMDD): CR only, dosing 12.5–25 mg daily, either continuously or cyclically starting 14 days before menstruation. Recommended for at least 3 cycles; dose adjustments weekly. - Obsessive Compulsive Disorder (OCD): IR: Start 20 mg daily; Maintenance 20–60 mg; Max 60 mg Requires long-term treatment with weekly dose increases of 10 mg. - Post-Traumatic Stress Disorder (PTSD) & Generalized Anxiety Disorder (GAD): IR: Start 20 mg daily; Maintenance 20–50 mg; Max 50 mg Treatment duration up to 12 weeks with weekly dose titration. - Postmenopausal Symptoms: Mesylate capsules 7.5 mg daily, for managing vasomotor symptoms only. Geriatric Dosing - Typically initiated at lower doses (around 10 mg daily) with maintenance doses up to 40 mg for depression, OCD, PTSD, SAD, GAD, and panic disorder. - Weekly dose increases are advised with careful monitoring. - Avoid use for mild or transient anxiety linked to routine stress.

Store Pari CR 25 tablets in a cool, dry place protected from light and moisture. Keep the medication in its original container to ensure stability and potency. Ensure the tablets are out of reach of children and pets to prevent accidental ingestion.

Common adverse reactions include nausea, headache, dizziness, somnolence, dry mouth, sexual dysfunction, and gastrointestinal disturbances such as constipation or diarrhea. Serious but rare effects include serotonin syndrome, increased bleeding risk, and withdrawal symptoms if stopped abruptly. Patients should be monitored regularly to manage side effects effectively.